Veri Medtech Holdings Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2011	FY 2010	FY 2009
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '11 Dec 31, 2011	Dec '10 Dec 31, 2010	Dec '09 Dec 31, 2009
Revenue	11.89	16.65	22.16	0.06	0.06	0.06
Revenue Growth (YoY)	-46.35%	-24.84%	34117.17%	8.88%	-6.46%	-
Cost of Revenue	3.04	4.26	6.07	0.01	0.02	0.05
Gross Profit	8.85	12.39	16.08	0.05	0.04	0.01
Selling, General & Admin	10.19	12.69	12.5	0.09	0.07	0.09
Other Operating Expenses	-	-	-	0	-	-
Operating Expenses	10.19	12.69	12.5	0.09	0.07	0.09
Operating Income	-1.34	-0.3	3.58	-0.04	-0.03	-0.08
Interest Expense	-0.1	-0.11	-0.1	-0.01	-0	-
Other Non Operating Income (Expenses)	-0	-0	0.05	-	-	-
EBT Excluding Unusual Items	-1.44	-0.41	3.53	-0.05	-0.04	-0.08
Gain (Loss) on Sale of Assets	-	-	-	-0.3	-	-
Pretax Income	-1.44	-0.41	3.53	-0.35	-0.04	-0.08
Net Income	-1.44	-0.41	3.53	-0.35	-0.04	-0.08
Net Income to Common	-1.44	-0.41	3.53	-0.35	-0.04	-0.08
Shares Outstanding (Basic)	18	12	10	2	1	1
Shares Outstanding (Diluted)	18	12	10	2	1	1
Shares Change (YoY)	72.60%	11.24%	440.21%	35.18%	27.82%	-
EPS (Basic)	-0.08	-0.04	0.34	-0.18	-0.03	-0.07
EPS (Diluted)	-0.08	-0.04	0.34	-0.18	-0.03	-0.07
Free Cash Flow	0.17	0.05	3.35	-0.34	0.01	0.18
Free Cash Flow Per Share	0.01	0.01	0.33	-0.18	0.01	0.17
Gross Margin	74.42%	74.39%	72.59%	81.12%	63.06%	15.93%
Operating Margin	-11.27%	-1.81%	16.18%	-61.49%	-53.89%	-118.74%
Profit Margin	-12.11%	-2.46%	15.93%	-536.33%	-60.54%	-118.74%
Free Cash Flow Margin	1.43%	0.32%	15.14%	-525.76%	10.93%	290.11%
EBITDA	-1.33	-0.3	3.58	-0.04	-	-
EBITDA Margin	-11.21%	-1.78%	16.18%	-61.42%	-	-
D&A For EBITDA	0.01	0.01	0	0	-	-
EBIT	-1.34	-0.3	3.58	-0.04	-0.03	-0.08
EBIT Margin	-11.27%	-1.81%	16.18%	-61.49%	-53.89%	-118.74%
Advertising Expenses	-	-	-	0.03	0.04	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.